LAUREN GREENHAW: Open Payments
NPI 1952599615 · BENTONVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,249 in 60 payments from 15 companies in 2025. Trend: 2023 $1,429 · 2024 $1,588 · 2025 $1,249
Food & beverage: $1,249
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $253 |
| Novo Nordisk Inc | 8 | $233 |
| PFIZER INC. | 10 | $188 |
| ABBVIE INC. | 8 | $146 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $97 |
| Amgen Inc. | 4 | $64 |
| Exact Sciences Corporation | 3 | $63 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $45 |
| SANOFI-AVENTIS U.S. LLC | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
Products named: Ozempic, FARXIGA, QULIPTA, NURTEC ODT, Kerendia, AIRSUPRA, Cologuard Collection Kit, Wegovy.
Industry payments across AR — which companies pay providers there.
